Bell Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.91K | Buy |
47
+17
| +57% | +$2.14K | ﹤0.01% | 910 |
|
|
2025
Q1 | $3.32K | Hold |
30
| – | – | ﹤0.01% | 1099 |
|
|
2024
Q4 | $4.1K | Buy |
30
+9
| +43% | +$1.23K | ﹤0.01% | 1015 |
|
|
2024
Q3 | $2.42K | Hold |
21
| – | – | ﹤0.01% | 1270 |
|
|
2024
Q2 | $2.89K | Hold |
21
| – | – | ﹤0.01% | 1196 |
|
|
2024
Q1 | $2.9K | Hold |
21
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q4 | $2.77K | Sell |
21
-9
| -30% | -$1.19K | ﹤0.01% | 1191 |
|
|
2023
Q3 | $3.38K | Sell |
30
-4
| -12% | -$450 | ﹤0.01% | 1013 |
|
|
2023
Q2 | $3.21K | Sell |
34
-5
| -13% | -$472 | ﹤0.01% | 1052 |
|
|
2023
Q1 | $3.95K | Buy |
39
+5
| +15% | +$506 | ﹤0.01% | 892 |
|
|
2022
Q4 | $4.06K | Buy |
34
+4
| +13% | +$478 | ﹤0.01% | 916 |
|
|
2022
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 949 |
|
|
2022
Q2 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 978 |
|
|
2021
Q4 | – | Sell |
-19
| Closed | -$2K | – | 1892 |
|
|
2021
Q3 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 1110 |
|